Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.385EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.385ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.385ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.385EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.385EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.385ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.384EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.384ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.384ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.384EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.384EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.384ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.384ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BY.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BY.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BY.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BY.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used